NCT06530888

Brief Summary

The main objective is to explore the feasibility of Process-based Therapy in a natural mental health care setting delivered by practitioners.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 4, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

July 27, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

July 31, 2024

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

March 19, 2026

Status Verified

March 1, 2026

Enrollment Period

2.4 years

First QC Date

July 27, 2024

Last Update Submit

March 17, 2026

Conditions

Keywords

feasibilityProcess-based Therapy

Outcome Measures

Primary Outcomes (5)

  • Client Satisfaction Questionnaire (CSQ)

    Treatment satisfaction , minimum value= 8, maximum value= 32, higher scores mean better outcome

    From the time of randomization until the end of treatment, assessed no later than 28 weeks

  • Patient attitude towards utility of EMA and networks Scale (PAUEN)

    Attitude towards utility of EMA and network models, minimum value= 8, maximum value= 40, higher scores mean better outcome

    From the time of randomization until the end of treatment, assessed no later than 28 weeks

  • Therapist attitude towards utility of EMA and networks Scale (TAUEN)

    Attitude towards utility of EMA and network models, minimum value= 6, maximum value= 30, higher scores mean better outcome

    From the time of randomization until the end of treatment, assessed no later than 28 weeks

  • Treatment Evaluation Inventory (TEI)

    Acceptance of treatment, minimum value= 7, maximum value= 98, higher scores mean better outcome

    From the time of randomization until the end of treatment, assessed no later than 28 weeks

  • Attrition rate

    The percentage of participants who withdraw before completing the final assessment

    From the time of randomization until the end of treatment, assessed no later than 28 weeks

Secondary Outcomes (9)

  • Euroqol-5D (EQ-5D)

    Assessed after randomization and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment

  • Positive-Mental Health Scale (PMH)

    Assessed after randomization and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment

  • Depression Anxiety Stress Scale (DASS-10)

    Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment (week 28)

  • Acceptance and Action Questionnaire Version 2 (AAQ-2)

    Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment

  • Reflective Functioning Questionnaire (RFQ-8)

    Assessed after randomization, after completion of the EMA baseline phase (intermediate) and assessed until the end of treatment, assessed no later than 28 weeks at post-treatment

  • +4 more secondary outcomes

Study Arms (2)

Process-based Cognitive Behavioral Therapy

EXPERIMENTAL

In PBT, treatment planning is based on a dynamic network analysis of EMA data collected during the baseline phase. Therapists identify the central node, significant edges, self-loops, and feedback loops between the nodes. Using this information, interventions are selected based on empirical evidence for mechanisms of change that correspond to the network characteristics. These interventions are framed within an evolutionary framework as the variation, selection, and retention of an adaptive mode of the central node in relation to the specific context of the problem. The change in this key variable is monitored through daily judgments based on EMA. Treatment also focuses on additional targets to establish adaptive modes of the dimensions as defined in the positive network model. Concomitant medication is allowed and will be controlled in statistical analyses.

Other: Process-based Cognitive Behavioral Therapy (PBT)

Routine practice (r-PT)

ACTIVE COMPARATOR

In r-PT, as opposed to PBT, a naturalistic setting is retained for treatment decisions. Treatment planning follows traditional theories about the factors maintaining the disorder and interventions changing them, e.g. avoidance and exposure in anxiety disorders or reduced reinforcement of activities and behavioral activation in depression. Interventions are based on common treatment manuals related to diagnoses, e.g. CBT for depression. Individual data from the behavioral analysis are used to tailor the techniques to the individual problems of the patients. Treatment process is largely structured by personal preferences of the therapist due to experience, knowledge or recommendations of the National guidelines for the mental health problem.Concomitant medication is allowed and will be controlled in statistical analyses.

Other: Routine practice (r-PT)

Interventions

Intervention planning as usual.

Routine practice (r-PT)

Intervention planning based on the use of EMA data, feedback of dynamic network analysis and matching of interventions to central nodes of the network.

Also known as: Process-based Therapy with Ecological Momentary Assessment
Process-based Cognitive Behavioral Therapy

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A primary DSM-5 diagnosis of a depressive or anxiety disorder
  • Age 18-65 years
  • Sufficient knowledge of the German language
  • Participating patients are not required to discontinue medication, but to keep medication constant over the treatment period

You may not qualify if:

  • Increased suicidality
  • Substance abuse or dependency
  • Diagnose of a cluster A or B (DSM-5) personality disorder
  • Pervasive developmental disorder
  • Psychotic disorder
  • Eating disorder
  • Bipolar disorder
  • Severe physical illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

JWGUniversity

Frankfurt am Main, Hesse, 60486, Germany

Location

Related Links

MeSH Terms

Conditions

Depressive DisorderAnxiety Disorders

Interventions

Ecological Momentary Assessment

Condition Hierarchy (Ancestors)

Mood DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Psychological TestsBehavioral Disciplines and Activities

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director of the Department of Clinical Psychology and Psychotherapy and Center for Psychotherapy

Study Record Dates

First Submitted

July 27, 2024

First Posted

July 31, 2024

Study Start

November 4, 2023

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

March 19, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results reported in the main publication of outcomes, after deidentification (text, tables, figures, and appendices) will be shared. Further Study Protocol, Analysis Plan, Informed Consent Form and Analytic Code will be shared to researchers who provide a methodologically sound proposal.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Beginning 3 months and ending 5 years following article publication. Data are available for 5 years at a third-party website (Link to be included).
Access Criteria
Proposals should be directed to stangier@psych.uni-frankfurt.de. To gain access, data requestors will need to sign a data access agreement.

Locations